全文获取类型
收费全文 | 749篇 |
免费 | 30篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 14篇 |
妇产科学 | 6篇 |
基础医学 | 76篇 |
口腔科学 | 10篇 |
临床医学 | 42篇 |
内科学 | 181篇 |
皮肤病学 | 12篇 |
神经病学 | 53篇 |
特种医学 | 37篇 |
外科学 | 193篇 |
综合类 | 15篇 |
预防医学 | 20篇 |
眼科学 | 3篇 |
药学 | 27篇 |
肿瘤学 | 94篇 |
出版年
2023年 | 5篇 |
2022年 | 9篇 |
2021年 | 15篇 |
2020年 | 13篇 |
2019年 | 6篇 |
2018年 | 15篇 |
2017年 | 8篇 |
2016年 | 10篇 |
2015年 | 10篇 |
2014年 | 12篇 |
2013年 | 17篇 |
2012年 | 26篇 |
2011年 | 25篇 |
2010年 | 24篇 |
2009年 | 25篇 |
2008年 | 39篇 |
2007年 | 63篇 |
2006年 | 47篇 |
2005年 | 42篇 |
2004年 | 47篇 |
2003年 | 28篇 |
2002年 | 40篇 |
2001年 | 26篇 |
2000年 | 20篇 |
1999年 | 16篇 |
1998年 | 6篇 |
1997年 | 12篇 |
1996年 | 10篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 10篇 |
1991年 | 8篇 |
1990年 | 8篇 |
1989年 | 11篇 |
1988年 | 11篇 |
1987年 | 9篇 |
1986年 | 10篇 |
1985年 | 7篇 |
1984年 | 7篇 |
1983年 | 7篇 |
1982年 | 9篇 |
1978年 | 3篇 |
1977年 | 6篇 |
1976年 | 10篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1973年 | 7篇 |
1971年 | 7篇 |
1970年 | 4篇 |
1965年 | 3篇 |
排序方式: 共有786条查询结果,搜索用时 15 毫秒
81.
Headache in lacunar stroke 总被引:1,自引:0,他引:1
The presence of headache within a 72-h interval of stroke onset was investigated in a cohort of 145 lacunar infarcts. Fourteen (10%) experienced diffuse or bilateral headache. Hypertension was less frequent (43 vs 76%; 95% CI: 6 to 60%) and of shorter duration (2.4 vs 7.8 years; t = 2.29; p = 0.02) among patients with headache. Leukoaraiosis was less frequent (40% vs 71%; 95% CI: −57 to −7%) and severe (7 vs 24%; 95% CI: −33 to −2%) in patients with headache. Age, sex, stroke risk factors, type of lacunar stroke, mode of onset, stroke severity, ultrasound and other CT findings were similar in patients with and without headache. No differences in the sixth month neurological or functional outcome were detected between lacunar patients with and without headache. Headache in lacunar stroke cannot be predicted by the clinical characteristics of the stroke and is not due to coexisting cardiembolism, intra or extracranial disease. Hypertensive small-vessel disease is less common and severe in lacunar strokes with associated headache. 相似文献
82.
Cyclosporin nephrotoxicity in heart and lung transplant patients 总被引:1,自引:0,他引:1
Griffiths MH; Crowe AV; Papadaki L; Banner NR; Yacoub MH; Thompson FD; Neild GH 《QJM : monthly journal of the Association of Physicians》1996,89(10):751-763
Twenty-two patients with heart, lung or heart and lung transplants
maintained on cyclosporin for periods ranging from 3 months to 10 years
developed renal insufficiency which was investigated by renal biopsy. The
histopathological changes were: (i) severe vascular and glomerular damage
due to thrombotic microangiopathy (TM); (ii) a form of focal segmental
glomerulosclerosis (FSGS); (iii) glomerular ischaemia. Rather than being
separate entities, these changes appeared to represent a spectrum of
pathology, some biopsies showing all three forms of glomerular injury. In
all cases the glomerular changes were accompanied by arteriolar and
arterial pathology, and we identified novel ultrastructural changes in the
arteriolar endothelial basal lamina. Tubular atrophy was a consistent
feature, the severity of which reflected the severity of the glomerular
sclerosis, and which appeared to be a consequence of glomerular loss. Our
findings are consistent with the nephrotoxic effects of cyclosporin being
mediated chiefly via damage to preglomerular vessels and glomerular
capillary endothelium. From an analysis of the clinical aspects of these
cases, the effects of cyclosporin appear to be to some extent
idiosyncratic, and therefore not entirely preventable, but strict
monitoring of blood cyclosporin levels is essential to minimize the risk of
permanent renal damage. Monitoring urinary protein in addition to plasma
creatinine may detect the onset of FSGS, as proteinuria precedes creatinine
elevation.
相似文献
83.
Shintaroh Koizumi Hiroki Kohno Michiko Watanabe Togo Iwahana Takuma Maeda Shigeki Miyata Yoshio Kobayashi Goro Matsumiya 《Journal of artificial organs》2018,21(4):462-465
Treating a patient with heparin-induced thrombocytopenia can be challenging particularly when the patient requires urgent cardiac surgery that uses heparin for anticoagulation. We herein report a case of a 61-year-old man with idiopathic dilated cardiomyopathy associated with heparin-induced thrombocytopenia and who underwent plasma exchange to remove heparin-induced thrombocytopenia antibodies before undergoing left ventricular assist device implantation. The surgery was performed using cardiopulmonary bypass and unfractionated heparin. 相似文献
84.
85.
Naohiro Ichino Yuji Horiguchi Hideo Imai Keisuke Osakabe Tohru Nishikawa Yukiko Sugita Hideko Utsugi Yoko Togo Tomoko Sawai Yoshikazu Mizoguchi 《Journal of Medical Ultrasonics》2006,33(1):29-35
Purpose The aim of this study was to evaluate the enhancement behavior of pancreatic ductal carcinoma by contrast-enhanced sonography
with agent detection imaging (ADI), and to clarify the origin of microbubble signals by comparisons with histological findings
of resected specimens.
Methods The subjects were 21 patients with resectable pancreatic carcinoma. The final histological diagnosis was tubular adenocarcinoma
in 20 cases, and anaplastic carcinoma in one case. Ultrasound examinations were performed using an Acuson Sequoia 512 series
system, and the contrast agent (Levovist) was injected intravenously in doses of 7 ml (300 mg/ml). The ADI signals (in the
tumor) were recorded continuously for 30 s after an injection of Levovist (vascular image) and then obtained intermittently
(30 s time-intervals) until the signal had diminished in pancreatic tissue (perfusion image).
Results Contrast enhancement of the tumor was observed in 71.4% of subjects on the vascular image and 76.3% of subjects on the perfusion
image. Enhancement patterns on the vascular image were classified into three types: VI-1 (linear enhancement), VI-2 (spotty
enhancement), and VI-3 (no enhancement). VI-1, VI-2, and VI-3 were seen in 9 (42.8%), 6 (28.6%), and 6 (28.6%) of the 21 cases,
respectively. Enhancement patterns on the perfusion image were classified into four types: PI-1 (diffuse uneven enhancement),
PI-2 (spotty enhancement), PI-3 (peripheral enhancement), and PI-4 (negative enhancement). The incidence of PI-1, PI-2, PI-3,
and PI-4 was 4.8%, 42.9%, 28.6%, and 23.8%, respectively. With respect to resectable cases, these enhancement patterns were
compared with histological findings, i.e., the distribution of blood vessels in the tumor, remaining pancreatic tissues in
the tumor, differentiation of types of adenocarcinoma, volume of stroma, and invasion types of carcinoma. The enhanced patterns
consequently corresponded to either the distribution of the blood vessels or the remaining pancreatic tissues in the tumor.
Conclusion This study indicated that pancreatic ductal carcinoma is frequently enhanced by microbubbles, and the signals seem to originate
from fine blood vessels and the remaining pancreatic tissues in the tumor. 相似文献
86.
Kazuhisa Takeda Kuniya Tanaka Daisuke Morioka Takafumi Kumamoto Itaru Endo Shinji Togo Hiroshi Shimada 《Clinical transplantation》2010,24(6):747-751
Takeda K, Tanaka K, Morioka D, Kumamoto T, Endo I, Togo S, Shimada H. Pathogenesis in ABO incompatible liver transplantation: a clinicohistological evaluation of four patients. Clin Transplant 2010: 24: 747–751. © 2009 John Wiley & Sons A/S. Abstract: The aim of this study was to clarify the pathogenesis of antibody‐mediated rejection (AMR) of ABO‐incompatible liver transplantation (ABO‐I‐LT). We investigated, within one month of surgery, the clinical courses of 10 patients who received ABO‐I‐LT. We encountered four cases of AMR, which were classified into two groups according to the stage of the AMR: early (within the first 14 postoperative days [PODs]) or late (after the 14th POD). There were three patients in the early stage, and one patient in the late stage. Three early‐stage AMR patients had both hyperbilirubinemia and thrombocytopenia within one month after LDLT, but the one late‐stage AMR patient had neither. On liver biopsy, hemorrhagic infiltration was seen more frequently in the early‐stage AMR patients than in the patient with late‐stage AMR. Plasma exchange combined with a large amount of gamma‐globulin bolus infusion therapy was effective in the three early‐stage patients, but the late‐stage AMR was controlled by antibiotic treatment. This study showed that the early‐stage AMR resulted from the antigen‐antibody reaction of ABO‐blood‐group antigens, while the late‐stage AMR may have been caused by an infection. 相似文献
87.
Yulia M. Ulybina Ekatherina Sh. Kuligina Nathalia V. Mitiushkina Nathalia Yu. Sherina Grigoriy A. Yanus Tatiana V. Gorodnova Anna S. Katanugina Andrey V. Koloskov Alexandr V. Togo Evgeny N. Imyanitov 《Experimental gerontology》2010
Our previous studies, which included genotyping of multiple coding apoptotic gene polymorphisms, unexpectedly demonstrated a depletion of heterozygous CASP5 Ala90Thr (rs507879, c.268 G > A) genotypes in elderly subjects. Present investigation was aimed to validate this trend. An analysis of 510 subjects aged 75–103 years revealed 205 (40%) CASP5 Ala90Thr heterozygotes as compared to 254 (50%) expected from the minor allele frequency 0.470 (p = 0.000014). This deviation was not observed in 549 middle-aged (18–50 years) controls (270 (49%) heterozygotes observed vs. 274 (50%) expected; minor allele frequency 0.475; p = 0.743). Unfavorable significance of CASP5 heterozygous genotype may be explained by the role of the caspase-5 in inflammation-related processes. Almost all prior gene-longevity association studies focused on discrimination between “good” and “bad” gene variants. Here we present a distinct situation, where the combination of alternative alleles (i.e., heterozygosity) appears to be unfavorable as compared to the homozygous carriership of either gene variant. 相似文献
88.
Michio Ueda Itaru Endo Masayuki Nakashima Yuta Minami Kazuhisa Takeda Kenichi Matsuo Yasuhiko Nagano Kuniya Tanaka Yasushi Ichikawa Shinji Togo Chikara Kunisaki Hiroshi Shimada 《World journal of surgery》2009,33(1):104-110
Objectives The purpose of this study was to identify important prognostic factors related to the status of a pancreatic tumor, its treatment,
and the patient’s general condition.
Methods Between April 1992 and December 2006, 140 patients underwent a pancreatic resection for invasive ductal carcinoma. Prognostic
factors were defined by univariate and multivariate analyses.
Results The study included 103 tumors in the head of the pancreas and 37 tumors in the body or tail. The median survival time and
the actuarial 5-year survival rate for all patients were 14.5 months and 12.3%, respectively. Using the significant prognostic
factors identified by univariate analysis, multivariate analysis revealed that a preoperative serum CA19-9 concentration >100
U/ml (HR = 1.84, p = 0.0074), a tumor size >3 cm (HR = 1.74, p = 0.0235), venous involvement (HR = 2.39, p = 0.0006), a transfusion requirement of ≥1000 ml (HR = 2.23, p = 0.0006), and a serum albumin concentration on 1 postoperative month (1POM) < 3 g/dl (HR = 2.40, p = 0.0009) were significant adverse prognostic factors. The presence of hypoalbuminemia on 1POM significantly correlated with
a longer surgical procedure (p = 0.0041), extended nerve plexus resection around the superior mesenteric artery (p = 0.0456), and a longer postoperative hospital stay (p = 0.0063).
Conclusion To improve long-term survival, preserving the patient’s general condition by performing a curative resection with a short
operation time and minimal blood loss should be the most important principle in the surgical treatment of pancreatic cancer. 相似文献
89.
Yasuhiko Nagano Hiroshi Shimada Michio Ueda Kenichi Matsuo Kuniya Tanaka Itaru Endo Chikara Kunisaki Shinji Togo 《ANZ journal of surgery》2009,79(10):729-733
Background: This study evaluated the efficacy of repeat hepatic resection for recurrent hepatocellular carcinoma (HCC) and the clinicopathological factors influencing overall survival after resection. Methods: From 1992 to 2005, 231 patients underwent curative hepatic resection for HCC at Yokohama City University, Japan. Of these, 105 patients developed intrahepatic recurrence, and 24 repeat hepatectomies were performed for recurrent HCC. Survival data were analysed, and prognostic factors for repeat hepatic resection were determined. Results: The overall cumulative 1‐, 3‐ and 5‐year survival rates and the median survival time of the patients after initial hepatic resection (n= 231) did not differ from those of the patients after repeat hepatic resection (n= 24), with values of 91.3, 70.2 and 49.1%, and 57 months, versus 91.7, 73.1 and 50.9%, and 61.5 months, respectively (P= 0.875). The operative time and blood loss in patients who underwent repeat hepatic resection did not differ from those who underwent primary resection. Multivariate analysis identified portal invasion at the first hepatic resection and a disease‐free interval of ≤1.5 years after primary hepatic resection as independent risk factors for survival after repeat hepatic resection. The 12 patients who did not show either of the two prognostic factors had 3‐ and 5‐year survival rates of 91.7 and 68.8%, respectively, after repeat hepatic resection. Conclusions: Our findings suggest repeat hepatic resection as the treatment of choice for recurrent HCC patients without portal invasion at the first resection whose recurrence develops after a disease‐free interval of >1.5 years since the previous surgery. 相似文献
90.
Background: This observational study was conducted in a small, 45 bed border static hospital, located in a field area, where no blood bank facilities were available. The present study was conducted to elucidate the blood transfusion practices of this hospital. 相似文献